AstraZeneca has said it made £3 billion from sales of its Covid jab last year.
The manufacturer, whose vaccine has been used around the globe in the battle to tackle the pandemic, also said that it expected revenues from coronavirus products to drop over the next year.
The group, which is not making a profit from the vaccine, notched up $1.76 billion (£1.3 billion) in sales from the Covid jab in the final three months of last year alone, with 2.5 billion doses released for supply around the world over the year as a whole.
